Profile
ACRX ZTS TAK HLN TEVA NBIX
Company Name AcelRx Pharmaceuticals, Inc. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $14.58M $53.87B $45.81B $43.16B $34.47B $15.32B
Employees 0.02K 13.80K 49.28K 24.56K 37.00K 1.80K
CEO Vincent J. Angotti Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Kyle W. Gano
Ratings
ACRX ZTS TAK HLN TEVA NBIX
Quant Rating Score 3 4 3 3 3 3
Quant Rating Neutral Buy Neutral Neutral Neutral Neutral
Trading
ACRX ZTS TAK HLN TEVA NBIX
Last Close $0.86 $118.8 $14.14 $9.68 $24.59 $143.56
High 52 $0.86 $178.71 $15.52 $11.41 $25.83 $154.8
Low 52 $0.86 $118.8 $12.89 $8.73 $12.82 $87.59
Price vs. 52 Week High 0 % -33.52 % -8.89 % -15.16 % -4.8 % -7.26 %
Price vs. 52 Week Low 0 % 0 % 9.7 % 10.88 % 91.81 % 63.9 %
Total Return
ACRX ZTS TAK HLN TEVA NBIX
1 Month Return 0 % -17.53 % 0.71 % 2.11 % 27.34 % 2.48 %
3 Month Return 0 % -21.96 % -6.73 % -0.05 % 36.16 % 7.83 %
6 Month Return 0 % -27.13 % 0.21 % -10.37 % 45.16 % 18.63 %
9 Month Return 0 % -24.08 % 1.73 % -3.1 % 48.4 % 25.96 %
YTD Return 0 % -27.09 % 6.8 % 1.47 % 11.57 % 5.17 %
1 Year Return 0 % -32.33 % 3.82 % 2.11 % 46.28 % 20.51 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACRX ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.64 % 4.41 % 1.56 % - -
Dividend Paid and Capex Coverage Ration (TTM) - 1.89 % 2.01 % 2.01 % 2.78 % 14.57 %
Dividend Per Share (TTM) - 2 % 198 % 0.06 % - -
Payout Ratio (TTM) - 32.55 % 226.17 % 27.27 % - -
Growth
ACRX ZTS TAK HLN TEVA NBIX
Asset Growth -10.59 % 0.76 % -9.55 % 14.37 %
Gross Profit Growth -100 % -0.19 % 5.47 % 25.65 %
Revenue Growth -100 % -0.61 % 4.41 % 24.81 %
Revenue 3 Year -100 % 19.01 % 1.52 % 95.79 %
Revenue 5 Year -100 % 33.95 % -5.5 % 172.74 %
Revenue 10 Year -100 % 33.95 % -38.45 % -
EBIT Growth 100 % 13.52 % 732.59 % 55.17 %
Net Income Growth -26.41 % 37.46 % -193.2 % 36.68 %
Net Income 3 Yeari Growth Per Share 86.26 % 4.91 % -482.97 % 258.91 %
Net Income 5 Yeari Growth Per Share 94.02 % 122.63 % -58.26 % 741.83 %
Net Income 10 Yeari Growth Per Share 94.76 % 122.63 % -140.46 % 518.75 %
Operating Income Growth 9.69 % 10.52 % -169.98 % 127.38 %
Operating Cash Flow Growth (CFG) 27.49 % 9.57 % 86.41 % 52.71 %
Operating 3 Year CFG 84.33 % 71.6 % 211.36 % 118.72 %
Operating 5 Year CFG 93.93 % 196.04 % 357.22 % 269.64 %
Operating 10 Year CFG 95.06 % 196.04 % -62.49 % 1038.19 %
EPS Growth -124185.71 % 33.33 % -190 % 32.81 %
EPS Diluted Growth -124185.71 % 33.33 % -190 % 33.2 %
Book Value Per Share -49.94 % -1.63 % -30.36 % 12.91 %
Share Holder 3 Year Equity Growth Per Share 108.27 % -37.97 % -49.06 % 77.59 %
Share Holder 5 Year Equity Growth Per Share 104.73 % -40.16 % -62.9 % 271.08 %
Share Holder 10 Year Equity Growth Per Share -97.7 % -40.16 % -82.62 % 821.72 %
Dividend Per Share Growth - 49.01 % - -
Dividend 3 Year Growth Per Share - -49.79 % - -
Dividend 5 Year Growth Per Share - -49.97 % -100 % -
Dividend 10 Year Growth Per Share - -49.97 % -100 % -
Debt Growth - 6.83 % -10.29 % 6.23 %
Free Cash Flow Growth 27.9 % 16.27 % 143.43 % 54.09 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ACRX ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 4874.07 % 70.63 % 52.77 % 61.81 % 49.6 % 98.37 %
Return on Assets TTM -68.45 % 17.49 % 0.98 % 4.78 % -0.39 % 10.03 %
Return on Equity TTM -151.4 % 53.56 % 1.95 % 9.4 % -2.58 % 15.82 %
Return on Capital Employed TTM -96.18 % 26.48 % 4.8 % 8.34 % 3.16 % 15.17 %
Net Income Per EBT TTM 99.36 % 79.59 % 72.4 % 76.52 % 222.54 % 68.09 %
EBT Per Ebit TTM 85.2 % 94.2 % 33.29 % 88.09 % -7.94 % 114.25 %
EBIT Per Revenue TTM -49459.26 % 37.63 % 12.68 % 20.49 % 5.38 % 20.51 %
Cash Flow To Debt Ratio TTM -178.61 % 1429.41 % 22.35 % 12.02 % 7.93 % 148.65 %
Receivables Turnover TTM - 6.1 6.59 5.14 4.67 3.69
Payables Turnover TTM 2.46 6.73 5.02 1.18 3.35 0.37
Inventory Turnover TTM - 1.12 1.71 3.72 2.4 0.63
Fixed Asset Turnover TTM - 241.44 % 229.02 % 589.57 % 321.73 % 473.81 %
Asset Turnover TTM 0.16 % 61.99 % 31.99 % 34.62 % 41.43 % 62.89 %
Operating Cash Flow Per Share TTM -0.34 6.58 643.53 0.11 1.21 6.41
Free Cash Flow Per Share TTM -0.34 5.06 521.29 0.1 0.78 5.97
Cash Per Share TTM 19.67 % 470.54 % 22368.59 % 7.46 % 188.4 % 1121.53 %
Operating Cash Flow Sales Ratio TTM -42992.59 % 31.03 % 22.48 % 9.32 % 8.36 % 23.74 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 76.82 % 81.01 % 90.65 % 64.03 % 93.14 %
Cash Flow Coverage Ratios TTM -178.61 % 1429.41 % 22.35 % 12.02 % 7.93 % 148.65 %
Price To Free Cash Flows Ratio TTM -2.17 24.05 8.68 34.34 39.1 25.82
Price To Operating Cash Flows Ratio TTM -3.64 18.57 6.98 31.66 25.03 24.04
Price Cash Flow Ratio TTM -3.64 18.57 6.98 31.66 25.03 24.04
Income Statement (TTM)
ACRX ZTS TAK HLN TEVA NBIX
Revenue $0B $9.26B $4581.55B $11.23B $16.54B $2.36B
Gross Profit $0B $6.4B $3001.33B $6.95B $8.06B $2.32B
Gross Profit Ratio 0% 69.1% 65.51% 61.85% 48.74% 98.56%
EBITDA $-0.02B $3.87B $1210.51B $2.51B $4.43B $0.64B
Net Income $-0.01B $2.49B $107.93B $1.44B $-1.64B $0.34B
EPS Diluted -0.87 5.47 33.62 0.32 -1.45 3.29
Balance Sheet (MRQ)
ACRX ZTS TAK HLN TEVA NBIX
Long Term Debt $0B $5.39B $3966.33B $8.62B $16.3B $0.46B
Total Liabilities $0.01B $9.47B $7312.37B $18.09B $33.61B $1.13B
Total Equity $0.01B $4.77B $6935.98B $16.22B $5.72B $2.59B
Total Investments $0B $0.03B $382.4B $0.14B $0B $1.71B
Total Debt $0B $6.74B $4515.27B $10.1B $18.08B $0.46B
Total Assets $0.02B $14.24B $14248.34B $34.32B $39.33B $3.72B
Cash Flow Statement (TTM)
ACRX ZTS TAK HLN TEVA NBIX
Net Income $-0.01B $2.5B $107.93B $1.44B $-1.65B $0.34B
Inventory $0B $-0.04B $-34.97B $0.22B $0B $-0.02B
Dividends Paid $0B $-0.79B $-302.5B $-0.57B $0B $0B
Operating Cash Flow $-0.01B $2.95B $1057.18B $2.3B $2.55B $0.6B
Capital Expenditure $0B $-0.66B $-200.8B $-0.25B $-0.5B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 6.265
ACOR Acorda Therapeutics, Inc. 0.661
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 0.8074
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 4.77
ALVOW Alvotech 0.7
AMPH Amphastar Pharmaceuticals, Inc. 26.125
AMRX Amneal Pharmaceuticals, Inc. 12.42
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 83.27
APUS Apimeds Pharmaceuticals US, Inc 1.94
AQST Aquestive Therapeutics, Inc. 5.875
ASRT Assertio Holdings, Inc. 0.7331
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 21.405
AYTU Aytu BioPharma, Inc. 2.48
ETFs With Exposure to ACRX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 334.74
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 148.03
VXF Vanguard Extended Market Index Fund 0 211.71
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 112.47
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 112.45
VQNPX Vanguard Growth and Income Fund 0 65.68
VGIAX Vanguard Quantitative Funds - Vanguard Growth and Income Fund 0 107.15
DFAS Dimensional U.S. Small Cap ETF 0 70.9
VTSAX Vanguard Total Stock Market Index Fund 0 160.97
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 158.72
VITSX Vanguard Total Stock Market Index Fund 0 160.99
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.0000338575 16.12
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 158.74
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
VEMPX Vanguard Extended Market Index InstlPlus 0 391.71
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 302.01
Unlock